PREVENTION OF LUNG FUNCTION DECLINE WITH VITAMIN E AND SELENIUM RESPIRATORY ANCI
PREVENTION OF LUNG FUNCTION DECLINE WITH VITAMIN E AND SELENIUM RESPIRATORY ANCI
批准号:
7952245
负责人:
ROWAN A CHLEBOWSKI
金额:
$0.47万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-12-01 至 2009-11-30
关键词:
AgeAgingAncillary StudyAntioxidantsAuthorization documentationBloodBlood specimenClinicalClinical ResearchClinical TrialsCollaborationsComputer Retrieval of Information on Scientific Projects DatabaseContusionsDataEligibility DeterminationFundingGrantHandwashingIncidenceInfectionInformed ConsentInstitutionLeftMalignant neoplasm of prostateMedicalMinorNursing StaffOral cavityParticipantPreventionPulmonary function testsRandomizedResearchResearch Ethics CommitteesResearch PersonnelResourcesRespiratory physiologyRiskSeleniumSiteSmokerSourceSpirometryStructureSyncopeTechniquesTestingTimeTrainingUnited States National Institutes of HealthVisitVitamin Edata managementprospectivepulmonary functionrespiratorysample collectionstatistical centerstatistics
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
The SELECT project is a multicenter randomized prospective clinical trial to assess the effect of Selenium and Vitamin E alone and in combination on the clinical incidence of prostate cancer. The RAS (IRB# 11798-01) is an ancillary study to SELECT, thus it is carried out completely within the SELECT structure. The RAS achieves its aims through collecting some additional medical information on a subset of SELECT participants. The RAS study sites are the 18 SELECT study sites. The RAS will target all participants or some of the participants, depending on the SELECT site. RAS participants must be an active SELECT participant and on Supplements at the time of registration to RAS.
The overall objective of the RAS is to understand whether supplemental antioxidants can slow the loss of lung function that occurs naturally with aging. This is particularly important for smokers, who have a more rapid loss of pulmonary function with increasing age. Informed consent and PHI authorization from potential participants is a requirement prior to registration to RAS at their initial visit. All RAS participants will be followed for four years and three spirometry tests and one time blood sample collection (at the SELECT third annual visit) will be done during this period.
The risk for RAS participants is minimal. Eligibility for spirometry will be tested at each visit to make sure it is safe for participants to perform the pulmonary function test. The risk of infection from the spirometry test is very minimal, because the mouth pieces are disposable and the gloves and proper hand washing techniques are used by the staff. The risk of fainting from spirometry is also minimized, because the test is done while sitting in a chair. A blood drawing could cause minor discomfort and/or leave a temporary bruise. Blood sample will be collected by a trained nursing staff, which should minimize likely complications of venopuncture.
In collaboration with the SELECT statistical center, the RAS staff will coordinate the administration, data management and the RAS coordinator center will conduct data review and statistic analysis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A PHASE III RANDOMIZED STUDY OF EXEMESTANE PLUS PLACEBO VERSUS EXEMESTANE PLU
-
批准号:8174479
-
项目类别:
-
资助金额:$32.99万
-
财政年份:2009
-
负责人:ROWAN A CHLEBOWSKI
-
依托单位:
LIFESTYLE INTERVENTION STUDY IN ADJUVANT TREATMENT OF EARLY BREAST CANCER (LISA)
-
批准号:8174504
-
项目类别:
-
资助金额:$0.83万
-
财政年份:2009
-
负责人:ROWAN A CHLEBOWSKI
-
依托单位:
THE INFLUENCE OF FIVE YEARS OF EXEMESTANE ON BONE MINERAL DENSITY
-
批准号:8174503
-
项目类别:
-
资助金额:$10.41万
-
财政年份:2009
-
负责人:ROWAN A CHLEBOWSKI
-
依托单位:
CLINICAL TRIAL: THE SELENIUM AND VITAMIN E CHEMOPREVENTION TRIAL (SELECT)
-
批准号:8174469
-
项目类别:
-
资助金额:$48.66万
-
财政年份:2009
-
负责人:ROWAN A CHLEBOWSKI
-
依托单位:
PREVENTION OF LUNG FUNCTION DECLINE WITH VITAMIN E AND SELENIUM RESPIRATORY ANCI
-
批准号:8174486
-
项目类别:
-
资助金额:$0.55万
-
财政年份:2009
-
负责人:ROWAN A CHLEBOWSKI
-
依托单位:
A PHASE III RANDOMIZED STUDY OF EXEMESTANE PLUS PLACEBO VERSUS EXEMESTANE PLU
-
批准号:7952230
-
项目类别:
-
资助金额:$29.5万
-
财政年份:2008
-
负责人:ROWAN A CHLEBOWSKI
-
依托单位:
CLINICAL TRIAL: THE SELENIUM AND VITAMIN E CHEMOPREVENTION TRIAL (SELECT)
-
批准号:7952213
-
项目类别:
-
资助金额:$48.51万
-
财政年份:2008
-
负责人:ROWAN A CHLEBOWSKI
-
依托单位:
THE INFLUENCE OF FIVE YEARS OF EXEMESTANE ON BONE MINERAL DENSITY
-
批准号:7952272
-
项目类别:
-
资助金额:$5.12万
-
财政年份:2008
-
负责人:ROWAN A CHLEBOWSKI
-
依托单位:
LIFESTYLE INTERVENTION STUDY IN ADJUVANT TREATMENT OF EARLY BREAST CANCER (LISA)
-
批准号:7952273
-
项目类别:
-
资助金额:$0.19万
-
财政年份:2008
-
负责人:ROWAN A CHLEBOWSKI
-
依托单位:
海外基金